CompletedNot Applicable

Prospective Analysis of In Vivo Laparoscopic Microwave Ablation Thermodynamics

United States60 participantsStarted 2022-02-14

Plain-language summary

To prospectively collect and evaluate pre-operative, intra-operative, and post-operative variables for all patients undergoing surgical microwave ablation. All patients who have a surgical microwave ablation with the Neuwave system will be added to the database after their treatment and procedures have been completed.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults with hepatic tumors (Age \>18 years or older) * Treatment included microwave ablation with the Neuwave system Exclusion Criteria: * Age \<18 * Benign Tumors * Patients whose initial treatment plan did not include MWA, although they later received one (rescue MWA) * Multiple tumors with distances or geometric relations rendering volumetrics incalculable or unduly confounded

What they're measuring

Prospective Power/Time Analysis of In Vivo Laparoscopic Microwave Ablation Thermodynamics in Hepato-Pancreato-Biliary Sold Tumors Utilizing a Single Generator at a Single Surgical Center

Timeframe: Year 2

Trial details

NCT IDNCT05471596

SponsorWake Forest University Health Sciences

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-11-17

View on ClinicalTrials.gov More Liver Diseases trials